反应：BRCA1在人乳腺癌和卵巢癌细胞中的定位。 - Suppr

Suppr

超能文献

Response: Location of BRCA1 in Human Breast and Ovarian Cancer Cells.

作者信息

Chen Y, Chen P L, Riley D J, Lee W H, Allred D C, Osborne C K

出版信息

Science. 1996 Apr 5;272(5258):125-6. doi: 10.1126/science.272.5258.125.

DOI:10.1126/science.272.5258.125

PMID:17789966

Abstract

摘要

相似文献

Response: Location of BRCA1 in Human Breast and Ovarian Cancer Cells.

Science. 1996 Apr 5;272(5258):125-6. doi: 10.1126/science.272.5258.125.

Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.

J Natl Cancer Inst. 2008 Nov 5;100(21):1519-29. doi: 10.1093/jnci/djn345. Epub 2008 Oct 28.

Contribution of BRCA1 and BRCA2 to familial ovarian cancer: a gynecologic oncology group study.

Gynecol Oncol. 2002 May;85(2):255-9. doi: 10.1006/gyno.2002.6615.

Novel genomic rearrangements in the BRCA1 gene detected in Greek breast/ovarian cancer patients.

Eur J Cancer. 2007 Jan;43(2):443-53. doi: 10.1016/j.ejca.2006.09.021. Epub 2006 Dec 14.

BRCA1a has antitumor activity in TN breast, ovarian and prostate cancers.

Oncogene. 2007 Sep 6;26(41):6031-7. doi: 10.1038/sj.onc.1210420. Epub 2007 Mar 26.

A low frequency of non-founder BRCA1 mutations in Ashkenazi Jewish breast-ovarian cancer families.

Hum Mutat. 2002 Nov;20(5):352-7. doi: 10.1002/humu.10123.

Germline BRCA1-2 mutations in non-Ashkenazi families with double primary breast and ovarian cancer.

Gynecol Oncol. 2001 Nov;83(2):383-7. doi: 10.1006/gyno.2001.6431.

Familial clustering of site-specific cancer risks associated with BRCA1 and BRCA2 mutations in the Ashkenazi Jewish population.

Proc Natl Acad Sci U S A. 2006 Mar 7;103(10):3770-4. doi: 10.1073/pnas.0511301103. Epub 2006 Feb 28.

Functional characterization of a novel BRCA1-null ovarian cancer cell line in response to ionizing radiation.

Mol Cancer Res. 2007 Jan;5(1):35-45. doi: 10.1158/1541-7786.MCR-06-0234.

Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype-phenotype correlations.

Breast Cancer Res Treat. 2006 Jan;95(1):81-7. doi: 10.1007/s10549-005-9047-1. Epub 2005 Oct 27.

引用本文的文献

The Breast Cancer Protooncogenes HER2, BRCA1 and BRCA2 and Their Regulation by the iNOS/NOS2 Axis.

Antioxidants (Basel). 2022 Jun 17;11(6):1195. doi: 10.3390/antiox11061195.

BRCA1 and Its Network of Interacting Partners.

Biology (Basel). 2013 Jan 2;2(1):40-63. doi: 10.3390/biology2010040.

Functional characterization of BRCA1 and BRCA2: clues from their interacting proteins.

J Mammary Gland Biol Neoplasia. 1998 Oct;3(4):413-21. doi: 10.1023/a:1018788132560.

Screening of BRCA1 mutation using immunohistochemical staining with C-terminal and N-terminal antibodies in familial ovarian cancers.

Jpn J Cancer Res. 2000 Apr;91(4):399-409. doi: 10.1111/j.1349-7006.2000.tb00959.x.

Psoriasin (S100A7) expression and invasive breast cancer.

Am J Pathol. 1999 Dec;155(6):2057-66. doi: 10.1016/S0002-9440(10)65524-1.

BRCA1 is phosphorylated at serine 1497 in vivo at a cyclin-dependent kinase 2 phosphorylation site.

Mol Cell Biol. 1999 Jul;19(7):4843-54. doi: 10.1128/MCB.19.7.4843.

Cell cycle-dependent colocalization of BARD1 and BRCA1 proteins in discrete nuclear domains.

Proc Natl Acad Sci U S A. 1997 Oct 28;94(22):12075-80. doi: 10.1073/pnas.94.22.12075.

BRCA1 is a cell cycle-regulated nuclear phosphoprotein.

Proc Natl Acad Sci U S A. 1997 Jul 8;94(14):7138-43. doi: 10.1073/pnas.94.14.7138.

Localization of BRCA1 and a splice variant identifies the nuclear localization signal.

Mol Cell Biol. 1997 Jan;17(1):444-52. doi: 10.1128/MCB.17.1.444.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Response: Location of BRCA1 in Human Breast and Ovarian Cancer Cells.

作者信息

Chen Y, Chen P L, Riley D J, Lee W H, Allred D C, Osborne C K

出版信息

Science. 1996 Apr 5;272(5258):125-6. doi: 10.1126/science.272.5258.125.

DOI:10.1126/science.272.5258.125

PMID:17789966

Abstract

摘要

相似文献

Response: Location of BRCA1 in Human Breast and Ovarian Cancer Cells.

Science. 1996 Apr 5;272(5258):125-6. doi: 10.1126/science.272.5258.125.

Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.

J Natl Cancer Inst. 2008 Nov 5;100(21):1519-29. doi: 10.1093/jnci/djn345. Epub 2008 Oct 28.

Contribution of BRCA1 and BRCA2 to familial ovarian cancer: a gynecologic oncology group study.

Gynecol Oncol. 2002 May;85(2):255-9. doi: 10.1006/gyno.2002.6615.

Novel genomic rearrangements in the BRCA1 gene detected in Greek breast/ovarian cancer patients.

Eur J Cancer. 2007 Jan;43(2):443-53. doi: 10.1016/j.ejca.2006.09.021. Epub 2006 Dec 14.

BRCA1a has antitumor activity in TN breast, ovarian and prostate cancers.

Oncogene. 2007 Sep 6;26(41):6031-7. doi: 10.1038/sj.onc.1210420. Epub 2007 Mar 26.

A low frequency of non-founder BRCA1 mutations in Ashkenazi Jewish breast-ovarian cancer families.

Hum Mutat. 2002 Nov;20(5):352-7. doi: 10.1002/humu.10123.

Germline BRCA1-2 mutations in non-Ashkenazi families with double primary breast and ovarian cancer.

Gynecol Oncol. 2001 Nov;83(2):383-7. doi: 10.1006/gyno.2001.6431.

Familial clustering of site-specific cancer risks associated with BRCA1 and BRCA2 mutations in the Ashkenazi Jewish population.

Proc Natl Acad Sci U S A. 2006 Mar 7;103(10):3770-4. doi: 10.1073/pnas.0511301103. Epub 2006 Feb 28.

Functional characterization of a novel BRCA1-null ovarian cancer cell line in response to ionizing radiation.

Mol Cancer Res. 2007 Jan;5(1):35-45. doi: 10.1158/1541-7786.MCR-06-0234.

Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype-phenotype correlations.

Breast Cancer Res Treat. 2006 Jan;95(1):81-7. doi: 10.1007/s10549-005-9047-1. Epub 2005 Oct 27.

引用本文的文献

The Breast Cancer Protooncogenes HER2, BRCA1 and BRCA2 and Their Regulation by the iNOS/NOS2 Axis.

Antioxidants (Basel). 2022 Jun 17;11(6):1195. doi: 10.3390/antiox11061195.

BRCA1 and Its Network of Interacting Partners.

Biology (Basel). 2013 Jan 2;2(1):40-63. doi: 10.3390/biology2010040.

Functional characterization of BRCA1 and BRCA2: clues from their interacting proteins.

J Mammary Gland Biol Neoplasia. 1998 Oct;3(4):413-21. doi: 10.1023/a:1018788132560.

Screening of BRCA1 mutation using immunohistochemical staining with C-terminal and N-terminal antibodies in familial ovarian cancers.

Jpn J Cancer Res. 2000 Apr;91(4):399-409. doi: 10.1111/j.1349-7006.2000.tb00959.x.

Psoriasin (S100A7) expression and invasive breast cancer.

Am J Pathol. 1999 Dec;155(6):2057-66. doi: 10.1016/S0002-9440(10)65524-1.

BRCA1 is phosphorylated at serine 1497 in vivo at a cyclin-dependent kinase 2 phosphorylation site.

Mol Cell Biol. 1999 Jul;19(7):4843-54. doi: 10.1128/MCB.19.7.4843.

Cell cycle-dependent colocalization of BARD1 and BRCA1 proteins in discrete nuclear domains.

Proc Natl Acad Sci U S A. 1997 Oct 28;94(22):12075-80. doi: 10.1073/pnas.94.22.12075.

BRCA1 is a cell cycle-regulated nuclear phosphoprotein.

Proc Natl Acad Sci U S A. 1997 Jul 8;94(14):7138-43. doi: 10.1073/pnas.94.14.7138.

Localization of BRCA1 and a splice variant identifies the nuclear localization signal.

Mol Cell Biol. 1997 Jan;17(1):444-52. doi: 10.1128/MCB.17.1.444.